#vivo

- Johnson & Johnson Innovation - JJDC, Inc. (JJDC) today announced a USD $15 million commitment to Vivo Capital ...

- TransMedics announces that its OCS® Heart technology was used to preserve and assess the world's first series of ...

- Dr. Rongxiang Xu received the Golden Biatec 2013 International award from the Informal Economic Forum (IEF) Economic ...

- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical ...

-Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 monthsAn analysis of ...

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...

- Telefonica Digital and Microsoft Corp. today announced a multiyear strategic agreement to create a new Global Video ...

-     Five Prime Therapeutics, Inc. ("FivePrime") has entered into research and commercial ...

-     PEIpro(TM) further expands an already rich catalogue of innovative ...

-       - Polyplus-transfection celebrates 10 years of commercial growth and research and ...

-        - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

-        Polyplus-transfection SA, a privately-held company developing innovative ...

-    Polyplus-transfection SA, a privately-held company developing innovative solutions for the delivery ...

-        - The Additional Funds Will Enable the Company to Expand its Therapeutic ...